Apixio Inc., a San Mateo, Calif.-based data science company for healthcare, raised $19.3m in Series D venture capital funding. The round was led by SSM Partners with participation from First Analysis, and Bain Capital Ventures. In conjunction with the funding, Casey West, managing partner at SSM Partners, will join Apixio’s Board of Directors. The company intends to use the funds to develop new applications that create insights for appropriate care and quality measurement. Led by Darren Schulte, MD, CEO, Apixio provides a cognitive computing platform, which mines unstructured medical records, such as medical charts and Medicare-reported chronic condition data, for an accurate view of a patient’s chronic conditions to allow payers and providers to offer more targeted care delivery.
The company’s platform has analyzed data from more than six million patients to date.